Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga

Fastly Shares Pop On Takeover Speculation

Fastly Inc (NYSE:FSLY) is surging on a speculative rumor that it could be a takeover target by Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL). A company like Google could acquire Fastly to improve its content delivery network, the Deal.com reported. Fastly operated a content delivery network to help entities provide faster and more reliable online content. Fastly reported…

Benzinga

Mercury Systems Stock Slips After Jefferies Downgrade

Jefferies analyst Sheila Kahyaoglu downgraded Mercury Systems Inc (NASDAQ:MRCY) to Hold from Buy and raised the price target to $65 (an upside of 4.7%) from $62. Kahyaoglu notes that the stock had increased 30% since the company released its Q2 earnings on February 1, owing to solid momentum in the Defense sector and three activist…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

28 Stocks Moving In Friday's Mid-Day Session

Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million.

Benzinga

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

Benzinga

Here's How Much You Would Have Made Owning Carlyle Group Stock In The Last 5 Years

Carlyle Group (NASDAQ:CG) has outperformed the market over the past 5 years by 8.65% on an annualized basis producing an average annual return of 22.49%. Currently, Carlyle Group has a market capitalization of $15.92 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Elon Musk Says Robot Production Could Start In 2023

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said production on his proposed Optimus humanoid robot could begin as early as next year.

Benzinga

Looking Into Star Bulk Carriers Corphares's Recent Short Interest

Star Bulk Carriers Corphares's (NASDAQ:SBLK) short percent of float has risen 21.21% since its last report. The company recently reported that it has 2.92 million shares sold short, which is 3.2% of all regular shares that are available for trading.

Benzinga

Insurance Stocks Moving In Friday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

How To Attend Hooker Furnishings Q4 2022 Earnings Conference Call

Hooker Furnishings (NASDAQ:HOFT) will host a conference call at 09:00 AM ET on April 13, 2022, to discuss Q4 2022 earnings results.

Benzinga

Stocks That Hit 52-Week Lows On Friday

During Friday's morning session, 234 stocks hit new 52-week lows.

Benzinga

This Is What Whales Are Betting On Regeneron Pharmaceuticals

A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 11 strange trades.

Benzinga

Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide

U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

HSBC Slashes Price Targets On Alibaba, Baidu Due to China's Covid Surge, Regulatory Crackdown

HSBC analyst Charlene Liu cut the price target on Baidu Inc (NASDAQ:BIDU) to $180 from $195 (31.3% upside) and kept a Buy rating on the shares. The analyst now assumes a worse impact from COVID-19 on the company's core ad and cloud businesses and margins, seeing a recovery only in Q4. Liu reduced the price…

Benzinga

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

Kaleido Biosciences Inc (NASDAQ:KLDO) has delivered formal notice to voluntarily delist its common stock from NASDAQ as the Company will stop all operations. The Company expects to file a Form 25 with the Securities and Exchange Commission by April 18 to effect the voluntary delisting effective by April 28. The Board of…

Benzinga

Craig-Hallum Downgrades Apogee Enterprises Post Q4 Results

Apogee Enterprises Inc (NASDAQ:APOG) has been downgraded to Hold from Buy, and the price target lowered to $47 from $54 by Craig-Hallum analyst Eric Stine. According to the analyst, Apogee used to trade at a significant discount to building materials comps but now trades substantially in-line. Related: Apogee Enterprises Q4 Results Surpass Estimates, Provides FY23 Guidance…

Benzinga

Janssen Partner Genmab Loses Arbitration Over Darzalex Royalties

Johnson & Johnson's (NYSE:JNJ) Janssen has won an arbitration against Genmab A/S (NASDAQ:GMAB) on two matters related to their licensing pact for multiple myeloma drug Darzalex (daratumumab). The first issue around daratumumab arose because Janssen announced a deal with Halozyme Therapeutics Inc (NASDAQ: HALO) to develop a subcutaneous formulation of daratumumab. According to Janssen, Genmab must share…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Palo Alto Networks Whale Trades For April 08

Someone with a lot of money to spend has taken a bullish stance on Palo Alto Networks (NASDAQ:PANW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Analyzing Mondelez International Inc - Class A's Short Interest

Mondelez International Inc - Class A's (NASDAQ:MDLZ) short percent of float has fallen 4.0% since its last report. The company recently reported that it has 13.29 million shares sold short, which is 0.96% of all regular shares that are available for trading.

Benzinga

Why This Target Analyst Says Retail Stocks Could Experience 'Upward Bias' In Months Ahead

Target Corporation (NYSE: TGT) shares gained ground Friday after the discount retailer scored an upgrade on Wall Street. The Target Analyst: Gordon Haskett analyst Chuck Grom upgraded Target from Hold to Buy and raised the price target from $255 to $300.

Benzinga

Dogecoin, Tesla In Top 10 But This Crypto Is Robinhood's Top Recurring 'Buy' Asset

Large-cap cryptocurrencies remained popular among retail traders despite weaker price action in 2022.

Benzinga

Here's Why Truist Slashed Price Targets On AMD, Intel, Nvidia

Truist analyst William Stein warned against the sustained semiconductor rally due to a sudden negative shift in demand signals from a wide swath of computer, consumer, and communications OEMs to at least some of their semi-suppliers. The cuts mainly related to production in the second quarter, but demand throughout the…

Benzinga

Twitter Is A Ghost Town And Needs Elon Musk, CEO Of Trump's Competing Social Media Platform Says

The CEO of a media company founded by former President Donald Trump had an interesting take on why Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is taking a stake in and

Benzinga

Robinhood Shares Drop As Goldman Sachs Downgrades Rating To Sell

Goldman Sachs Group Inc analysts downgraded Robinhood Markets Inc (NASDAQ: HOOD) to Sell

1 … 757 758 759 760

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.